| Dr Richard Yoon, MD | |
|
733 W Clairemont Ave, Eau Claire, WI 54701-6101 | |
| (715) 838-5222 | |
| Not Available |
| Full Name | Dr Richard Yoon |
|---|---|
| Gender | Male |
| Speciality | Preventive Medicine |
| Experience | 10 Years |
| Location | 733 W Clairemont Ave, Eau Claire, Wisconsin |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1649590787 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 2083X0100X | Preventive Medicine - Occupational Medicine | 66763 (Wisconsin) | Primary |
| 207R00000X | Internal Medicine | 25MA08754100 (New Jersey) | Secondary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Clara Maass Medical Center | Belleville, NJ | Hospital |
| Mayo Clinic Health System-red Cedar Inc | Menomonie, WI | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Mayo Clinic Health System-northwest Wisconsin Region Inc | 4385553627 | 623 |
News Archive
Gem Pharmaceuticals announced today that the initial soft tissue sarcoma (STS) patients have been enrolled into the Company's Phase 2 clinical trial. This open-label study will assess the efficacy and safety of Gem's lead compound, GPX-150 (an investigational medication), in approximately 30 adults as first-line therapy for advanced or metastatic disease.
Sloppy shipping of a donated human retina to an Indiana University researcher studying a leading cause of vision loss has inadvertently helped uncover a previously undetected mechanism causing the disease. The discovery has led researchers to urge review of how millions of dollars are spent investigating the cause of a type of age-related macular degeneration called choroidal neovascularization.
A piece of legislation under consideration in Florida this week has received huge attention because of a controversial provision that would allow some teachers to have guns in schools. But the proposed law would also designate an influx of cash for mental health services.
Antares Pharma, Inc. today reported operating and financial results for the first quarter ended March 31, 2014.
› Verified 1 days ago
| Entity Name | Mayo Clinic Health System-northwest Wisconsin Region Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1235588831 PECOS PAC ID: 4385553627 Enrollment ID: O20161109002075 |
News Archive
Gem Pharmaceuticals announced today that the initial soft tissue sarcoma (STS) patients have been enrolled into the Company's Phase 2 clinical trial. This open-label study will assess the efficacy and safety of Gem's lead compound, GPX-150 (an investigational medication), in approximately 30 adults as first-line therapy for advanced or metastatic disease.
Sloppy shipping of a donated human retina to an Indiana University researcher studying a leading cause of vision loss has inadvertently helped uncover a previously undetected mechanism causing the disease. The discovery has led researchers to urge review of how millions of dollars are spent investigating the cause of a type of age-related macular degeneration called choroidal neovascularization.
A piece of legislation under consideration in Florida this week has received huge attention because of a controversial provision that would allow some teachers to have guns in schools. But the proposed law would also designate an influx of cash for mental health services.
Antares Pharma, Inc. today reported operating and financial results for the first quarter ended March 31, 2014.
› Verified 1 days ago
| Entity Name | Mayo Clinic Health System-northwest Wisconsin Region Inc |
|---|---|
| Entity Type | Part A Provider - Critical Access Hospital |
| Entity Identifiers | NPI Number: 1154372944 PECOS PAC ID: 4385553627 Enrollment ID: O20171012000001 |
News Archive
Gem Pharmaceuticals announced today that the initial soft tissue sarcoma (STS) patients have been enrolled into the Company's Phase 2 clinical trial. This open-label study will assess the efficacy and safety of Gem's lead compound, GPX-150 (an investigational medication), in approximately 30 adults as first-line therapy for advanced or metastatic disease.
Sloppy shipping of a donated human retina to an Indiana University researcher studying a leading cause of vision loss has inadvertently helped uncover a previously undetected mechanism causing the disease. The discovery has led researchers to urge review of how millions of dollars are spent investigating the cause of a type of age-related macular degeneration called choroidal neovascularization.
A piece of legislation under consideration in Florida this week has received huge attention because of a controversial provision that would allow some teachers to have guns in schools. But the proposed law would also designate an influx of cash for mental health services.
Antares Pharma, Inc. today reported operating and financial results for the first quarter ended March 31, 2014.
› Verified 1 days ago
| Entity Name | Mayo Clinic Health System-northwest Wisconsin Region Inc |
|---|---|
| Entity Type | Part A Provider - Critical Access Hospital |
| Entity Identifiers | NPI Number: 1740239557 PECOS PAC ID: 4385553627 Enrollment ID: O20171012000112 |
News Archive
Gem Pharmaceuticals announced today that the initial soft tissue sarcoma (STS) patients have been enrolled into the Company's Phase 2 clinical trial. This open-label study will assess the efficacy and safety of Gem's lead compound, GPX-150 (an investigational medication), in approximately 30 adults as first-line therapy for advanced or metastatic disease.
Sloppy shipping of a donated human retina to an Indiana University researcher studying a leading cause of vision loss has inadvertently helped uncover a previously undetected mechanism causing the disease. The discovery has led researchers to urge review of how millions of dollars are spent investigating the cause of a type of age-related macular degeneration called choroidal neovascularization.
A piece of legislation under consideration in Florida this week has received huge attention because of a controversial provision that would allow some teachers to have guns in schools. But the proposed law would also designate an influx of cash for mental health services.
Antares Pharma, Inc. today reported operating and financial results for the first quarter ended March 31, 2014.
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Richard Yoon, MD Po Box 1510, Eau Claire, WI 54702-1510 Ph: (715) 838-5222 | Dr Richard Yoon, MD 733 W Clairemont Ave, Eau Claire, WI 54701-6101 Ph: (715) 838-5222 |
News Archive
Gem Pharmaceuticals announced today that the initial soft tissue sarcoma (STS) patients have been enrolled into the Company's Phase 2 clinical trial. This open-label study will assess the efficacy and safety of Gem's lead compound, GPX-150 (an investigational medication), in approximately 30 adults as first-line therapy for advanced or metastatic disease.
Sloppy shipping of a donated human retina to an Indiana University researcher studying a leading cause of vision loss has inadvertently helped uncover a previously undetected mechanism causing the disease. The discovery has led researchers to urge review of how millions of dollars are spent investigating the cause of a type of age-related macular degeneration called choroidal neovascularization.
A piece of legislation under consideration in Florida this week has received huge attention because of a controversial provision that would allow some teachers to have guns in schools. But the proposed law would also designate an influx of cash for mental health services.
Antares Pharma, Inc. today reported operating and financial results for the first quarter ended March 31, 2014.
› Verified 1 days ago
Andrew E Floren, MD Preventive Medicine Medicare: Accepting Medicare Assignments Practice Location: 733 W Clairemont Ave, Eau Claire, WI 54701 Phone: 715-838-5222 | |
Joseph T Hebl, MD Preventive Medicine Medicare: Not Enrolled in Medicare Practice Location: 733 W Clairemont Ave, Eau Claire, WI 54701 Phone: 715-838-5222 | |
Dr. Linda Go, M.D. Preventive Medicine Medicare: Accepting Medicare Assignments Practice Location: 900 W Clairemont Ave, Eau Claire, WI 54701 Phone: 715-723-9138 |